BEACN and London Drugs Announce Retail Partnership

Two Canadian tech-minded companies work together to help content creators, streamers and gamers.

VICTORIA, BC, Sep. 26, 2023 [ACCESSWIRE] — BEACN, a leading Canadian innovator in audio technology, is thrilled to announce its retail partnership with London Drugs, one of Canada’s most trusted and established retail chains. This exciting collaboration marks a significant step forward in the availability of BEACN’s premium audio products to a wider audience of content creators and tech enthusiasts. BEACN products are now available for purchase on the London Drugs website and will be available at in-store locations starting October 27, 2023. 

  BEACN products will be available at London Drugs online and in store October 27, 2023 – photo credit: BEACN 2023   

London Drugs, a household name known for providing high-quality electronics and consumer goods, is committed to offering the latest and most innovative tech products to its customers. By partnering with BEACN, London Drugs is further strengthening its position as a destination for cutting-edge content solutions. 

“Our TECH department is thrilled to unveil these remarkable USB Microphones and Sound Mixers in Canadian retail. We recognize that gamers, streamers, and remote professionals have a discerning taste for exceptional audio quality. BEACN not only meets but exceeds these expectations – delivering outstanding sound performance plus, they boast an impressive visual design,” says Darren Bilawchuk, Merchandising Manager London Drugs.

BEACN is renowned for its state-of-the-art audio products that cater to the needs of content creators – YouTubers, podcasters, Twitch streamers, WFH, and other creatives. BEACN solutions include studio-quality microphones, audio controllers and peripherals that deliver unparalleled audio quality and control, making them the ideal choice for anyone looking to elevate their audio game. 

“We are excited to partner with London Drugs, a respected customer-focused retail leader, to make our products more accessible to consumers across Canada,” said Craig Fraser, CEO at BEACN. “This partnership not only reflects our dedication to delivering the best audio experiences but also ensures that content creators and tech enthusiasts have access to the tools they need to bring their creative visions to life.” 

Media & Investors Enquiries

Daniel Davies

+1 (778) 561-1450 


BEACN (TSX-V: BECN), a Victoria BC based consumer electronics company, develops innovative audio equipment, peripherals and technology for gamers, live streamers, and content creators. BEACN is committed to delivering premium products that enable everyone to produce studio-quality content. BEACN’s award-winning product ecosystem includes BEACN Mic, BEACN Mix and BEACN Mix Create. BEACN is listed on the TSXV under the symbol BEACN.

About London Drugs   

Founded in 1945, B.C.-based London Drugs sells to every province and territory in Canada through its online store, and has 80 London Drugs locations throughout BC  in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan and Manitoba. London Drugs offers customers a range of products from personal protection equipment for pandemic safety to digital cameras and cosmetics to computers and televisions. Renowned for its creative approach to retailing, the company employs more than 9,000 people with pharmacy and healthcare services at the heart of its business. Committed to innovation and superior customer service, London Drugs has established itself as a reputable and caring Canadian company that supports Canadian brands and continues to position itself for future growth and development.   

Social media

: /LondonDrugs   

Twitter: @LondonDrugs   

Instagram: @LondonDrugs   

Hashtag Intel:   #LondonDrugs   

London Drugs Media Contact 

Louise Stoddart  


(604) 351-3623  

Reader Advisory 

Certain information set forth in this news release contains forward-looking statements or information (“forward-looking ‎statements”), including details about the proposed Offering and the Company’s proposed use of proceeds from the Offering. By their nature, forward-looking statements are subject to numerous risks ‎and uncertainties, some of which are beyond the Corporation’s control, including risks associated with the inability to complete the Offering, timing of receipt of regulatory approval, change in market conditions, evolving global supply chain issues, evolving economic and political issues, and demand for BEACN products.  

Although the ‎Company believes that the expectations in its forward-looking statements are reasonable, its forward-looking statements have ‎been based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and ‎assumptions are based upon currently available information. Such statements are subject to known and unknown risks, ‎uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially ‎from those stated, anticipated, or implied in the forward-looking statements. Accordingly, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. ‎ Furthermore, the forward-looking statements contained in this document are made as of ‎the date of this document and, except as required by applicable law, the Company does not undertake any obligation to publicly ‎update or to revise any of the included forward-looking statements, whether as a result of new information, future events or ‎otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.‎ 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.